Phil L'Huillier, Scancell CEO, on the Latest Developments in Cancer Vaccines

The latest episode of the In Vivo podcast features an interview with Phil L'Huillier, who discusses the inclusion of Scancell's melanoma cancer vaccine on the NHS Cancer Vaccine Launch Pad, and how 2025 could be a pivotal year for the cancer vaccine field as a whole.

Episode metadata supplied by the publisher feed · Published Jul 9, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Phil L'Huillier, Scancell CEO, on the Latest Developments in Cancer Vaccines

0:00 27:23

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Citeline Podcasts?

This episode is 27 minutes long.

When was this Citeline Podcasts episode published?

This episode was published on July 9, 2025.

Can I download this Citeline Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!